EZH2 and acute myeloid leukemia: In fact, it has been demonstrated that in resistant cell lines as well as in primary cells from relapsed AML patients, EZH2 is hyperphopshorylated at Thr487 by the cyclin-dependent kinase 1 via heat shock protein 90 (HSP90) stabilization and ultimately degraded by the proteasome.